175 related articles for article (PubMed ID: 3489518)
1. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
[TBL] [Abstract][Full Text] [Related]
2. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells.
Uede T; Kohda H; Ibayashi Y; Osawa H; Diamantstein T; Kikuchi K
J Immunol; 1985 Nov; 135(5):3243-51. PubMed ID: 3900205
[TBL] [Abstract][Full Text] [Related]
4. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
Vargo PM; Battisto JR
J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
[TBL] [Abstract][Full Text] [Related]
6. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
Wong HL; Battisto JR
Eur J Immunol; 1984 Jul; 14(7):629-33. PubMed ID: 6235115
[TBL] [Abstract][Full Text] [Related]
7. The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12.
Shinomiya Y; Harada M; Tamada K; Kurosawa S; Okamoto T; Terao H; Takenoyama M; Ito O; Hirashima C; Li T; Shirakusa T; Nomoto K
In Vivo; 1997; 11(1):1-8. PubMed ID: 9067765
[TBL] [Abstract][Full Text] [Related]
8. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
9. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
10. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
11. 'Autoreactivity' of some hybridomas may be caused by a three-cell interaction.
Aihara Y; Klein J
Immunology; 1988 Mar; 63(3):389-95. PubMed ID: 3258277
[TBL] [Abstract][Full Text] [Related]
12. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model].
Hori T; Kan N; Inamoto T; Nio Y; Ohgaki K; Kodama H; Tobe T
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027
[TBL] [Abstract][Full Text] [Related]
13. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
Izumi Y; Tsuchida T; Okuno K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Sep; 76(9):863-70. PubMed ID: 3932286
[TBL] [Abstract][Full Text] [Related]
14. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
15. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
Gautam SC; Hilfiker ML; Battisto JR
J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
[TBL] [Abstract][Full Text] [Related]
16. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
Dye ES
J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
18. Suppressor cells in the spleen of tumor-allosensitized mice.
Argyris BF
Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
[TBL] [Abstract][Full Text] [Related]
19. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
Bear HD; Susskind BM; Close KA; Barrett SK
Cancer Res; 1988 Mar; 48(6):1422-7. PubMed ID: 2964266
[TBL] [Abstract][Full Text] [Related]
20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
